Jane Street
MIST icon

Jane Street’s Milestone Pharmaceuticals MIST Stock Holding History

Jane Street’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21K Sell
24,300
-6,900
-22% -$7.66K ﹤0.01% 11279
2026
Q2 		$41.8K Sell
31,200
-10,300
-25% -$16.5K ﹤0.01% 11002
2026
Q1 		$49.4K Sell
41,500
-37,400
-47% -$65.5K ﹤0.01% 10976
2025
Q4 		$159K Buy
+78,900
New +$170K ﹤0.01% 9888

Other funds holding MIST

Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
RVW Wealth
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
October Effect
October Effect Virginia Beach, Virginia $98.3M AUM 66.25% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return

Jane Street's MIST Position: Q3 2026 in Review

Jane Street reduced its Milestone Pharmaceuticals (MIST) stake by 77% in Q3 2026, selling an estimated $49.4K and leaving 13,289 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #11397.

Jane Street first reported a position in MIST in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.21M in Q4 2025. 35 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

  • Jane Street held 13,289 shares of Milestone Pharmaceuticals worth $11.5K as of Q3 2026.
  • Jane Street sold 44,498 Milestone Pharmaceuticals shares in Q3 2026, an estimated $49.4K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11397 holding.
  • Jane Street first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Jane Street's Milestone Pharmaceuticals position peaked at $2.21M in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.